Track Onward Medical
— get Health deals in free daily digest
Overview
Onward Medical, a neurotechnology company based in Eindhoven, has raised €40.6 million through a private placement with institutional investors, including a €25 million investment from EQT Life Sciences. The company develops therapies to restore movement for individuals with spinal cord injuries using its proprietary arc therapy. The arc-ex® system is already approved for commercial use in the US and Europe, while the arc-im® system is under clinical evaluation. This funding supports their mission to advance these technologies.
Products
Loading...
Recent Deals
Investors: EQT Life Sciences
Onward Medical, a neurotechnology company based in Eindhoven, has raised €40.6 million through a private placement with institutional investors, including a €25 million investment from EQT Life Sciences. The company develops therapies to restore movement for individuals with spinal cord injuries using its proprietary arc therapy. The arc-ex® system is already approved for commercial use in the US and Europe, while the arc-im® system is under clinical evaluation. This funding supports their mission to advance these technologies.